Paul Abato Ph.D
35 Forest St. Providence, RI 02906
Recently, Dr. Abato had an engagement with Mylan where he wrote reports, was deposed by Pfizer's counsel for seven hours and was involved in federal pre-trial preparation up until the parties settled. Dr. Abato has 11 years of industrial experience at Paratek Pharmaceuticals in the discovery and development of novel human therapeutics, including tetracyclines, in the areas of anti-infective, antibacterial, acne, anti-inflammatory, arthritis, neurodegenerative diseases, and multiple sclerosis. Dr. Abato also co-authored a pre-IND proposal that had a favorable review by the FDA in January of 2013.